KHP Ventures

MediShout is a digital platform to improve operational efficiencies, so healthcare staff can focus on patient care. MediShout brings calmness to chaotic wards and turns hospitals into smart and automated buildings. Our technology connects staff, systems, machines, and work-flow; thus improving efficiency and care. Our cloud-based technology connects people, Helpdesks, smartphones, tablets, IT systems, and RFID tagging.

TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system empowers non-specialists to perform high definition digital otoscopy, microsuction wax removal and a hearing screening, all in a single 30 minute appointment. Users can also upload patient images and video to the secure cloud, where they can be reviewed by ENT specialists anywhere in the world.

52 North Health aims to improve healthcare with a medical device that uses artificial intelligence (AI) to determine the risk of neutropenic sepsis for patients undergoing chemotherapy.

Acurable is a MedTech start-up headquartered in London. Acurable commercializes a wearable medical device able to accurately diagnose and manage respiratory conditions in a non-invasive way. Its award-winning patented technology is a major engineering innovation and the product of 10 years of research at Imperial College London. Acurable's medical devices has more accurate readings than current solutions, enabling automated diagnosis and drastically reducing misdiagnosis. It is non-invasive and requires no training, enabling home use without the assistance of a specialist or a visit to the hospital, which significantly lowers overall costs. Acurable aims to understand human biosignals so well that nobody dies of a treatable condition ever again.

Apian provides an API for integrating drones into the healthcare environment. They build products and platforms that connect the healthcare industry with the drone industry, helping clients improve patients' health outcomes.

Doccla is the virtual ward company. We are the pioneers of tech-agnostic virtual wards. We partner with care organisations to enable early discharge and prevent hospital readmission by monitoring patients remotely using best of breed devices. Doccla’s Covid-19 support service evolved from a research project we were running for the NHS, and was designed collaboratively with Northampton General Hospital, where the service is now in live use.

Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a novel combination of sensor technologies and machine learning to enable non-invasive ICPM, the only proven way to improve outcomes in HF patients. The device has been clinically validated, designated FDA Breakthrough Device, and will enter the market in 2025. The company's product can non-invasively monitor cardiac and pulmonary pressure by utilizing machine-learning techniques to analyze pressure dynamics in acoustic, vibratory, and waveform data.